Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: Result of unchanged vascular Rho-kinase?

Liver International

Volumn 29, Issue 6, 2009, Pages 933-941

  Hennenberg, Martin ^a,b   Trebicka, Jonel ^a   Buecher, Doris ^a   Heller, Jörg ^a   Sauerbruch, Tilman ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Medizinische Klinik und Poliklinik I   (Germany)

Author keywords

Bacterial translocation; Cirrhosis; Hyperdynamic circulation; Nitric oxide; Portal hypertension; Rho kinase; Vasocontraction; Vasodilation

Indexed keywords

BETA ARRESTIN 2; CALCIUM ION; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; METHOXAMINE; MOESIN; NORFLOXACIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BACTERIAL GROWTH; BILE DUCT LIGATION; BILIARY CIRRHOSIS; CONTROLLED STUDY; HEMODYNAMIC PARAMETERS; LYMPH NODE; MALE; NONHUMAN; PORTAL HYPERTENSION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPLANCHNIC BLOOD FLOW; VASODILATATION; WESTERN BLOTTING;

ANIMALS; ANTI-BACTERIAL AGENTS; AORTA; BILE DUCTS; BLOTTING, WESTERN; ELECTROMYOGRAPHY; HYPERTENSION, PORTAL; LIGATION; LIVER CIRRHOSIS, BILIARY; LYMPH NODES; MALE; MICROSPHERES; NITRIC OXIDE SYNTHASE TYPE III; NORFLOXACIN; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; VASOCONSTRICTION;

EID: 67049114730     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02010.x     Document Type: Article

References (45)

1. Murray JF, Dawson AM, Sherlock S. Circulatory changes in chronic liver disease. Am J Med 1958; 24: 358-67.
2. Bosch J, Pizcueta MP, Fernandez M, et al. Hepatic, splanchnic and systemic haemodynamic abnormalities in portal hypertension. Baillieres Clin Gastroenterol 1992; 6: 425-36.
3. Gupta TK, Chen L, Groszmann RJ. Pathophysiology of portal hypertension. Clin Liver Dis 1997; 1: 1-12.
4. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough. Hepatology 2002; 35: 478-91.
5. Langer DA, Shah VJ. Nitric oxide and portal hypertension: Interface of vasoreactivity and angiogenesis. J Hepatol 2006; 44: 209-16.
6. Hennenberg M, Trebicka J, Sauerbruch T, Heller J. Mechanisms of extrahepatic vasodilation in portal hypertension. Gut 2008; 57: 1300-14.
7. Hennenberg M, Biecker E, Trebicka J, et al. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats. Gastroenterology 2006; 130: 838-54.
8. Hennenberg M, Trebicka J, Biecker E, et al. Vascular dysfunction in human and rat cirrhosis: Role of receptor-desensitizing and calcium-sensitizing proteins. Hepatology 2007; 45: 495-506.
9. Wiest R, Das S, Cadelina G, et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999; 104: 1223-33.
10. Wiest R, Cadelina G, Milstien S, et al. Bacterial translocation up-regulates GTP-cyclohydrolase I in mesenteric vasculature of cirrhotic rats. Hepatology 2003; 38: 1508-15.
11. Tazi KA, Moreau R, Herve P, et al. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. Gastroenterology 2005; 129: 303-14.
12. Garcia-Tsao G, Wiest R. Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 2004; 18: 353-72.
13. Münzel T, Feil R, Mülsch A, et al. Physiology and pathophysiology of vascular signaling controlled by cyclic guanosine 3′,5′-cyclic monophosphate-dependent protein kinase. Circulation 2003; 108: 2172-83.
14. Boer C, van Nieuw Amerongen GP, Groeneveld ABJ, et al. Smooth muscle F-actin disassembly and RhoA/Rho-kinase signaling during endotoxin-induced alterations in pulmonary arterial compliance. Am J Physiol Lung Cell Mol Physiol 2004; 287: L649-55.
15. Büyükafsar K, Arikan O, Ark M, Kubat H, Özveren E. Upregulation of Rho-kinase (ROCK-2) expression and enhanced contraction to endothelin-1 in the mesenteric artery from lipopolysaccharide-treated rats. Eur J Pharmacol 2004; 498: 211-7.
16. Rabiller A, Nunes H, Lebrec D, et al. Prevention of Gram-negative translocation reduces the severity of hepatopulmonary syndrome. Am J Crit Care Med 2002; 166: 514-7.
17. Llovet JM, Bartoli R, Planas R, et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 1996; 23: 781-7.
18. Runyon BA, Borzio M, Young S, et al. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology 1995; 21: 1719-24.
19. 4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology 2006; 44: 633-9.
20. Kakkos SK, Kirkilesis J, Scopa CD, et al. Nonabsorbable antibiotics reduce bacterial and endotoxin translocation in hepatectomised rats. HPB Surg 1997; 10: 283-9.
21. Seyde WC, Longnecker DE. Anesthetic influence on regional hemodynamics in normal and hemorrhaged rats. Anesthesiology 1984; 61: 686-98.
22. Van de Casteele M, Sägesser H, Zimmermann H, Reichen J. Characterization of portal hypertension models by microspheres in anaesthetised rats: A comparison of liver flow. Pharmacol Ther 2001; 90: 35-43.
23. Hakkinen JP, Miller MW, Smith AH, Knight DR. Measurement of organ blood flow with coloured microspheres in the rat. Cardiovasc Res 1995; 29: 74-9.
24. Bolz SS, Vogel L, Sollinger D, et al. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway. Circulation 2003; 107: 3081-7.
25. Shaw RJ, Henry M, Solomon F, Jacks T. RhoA-dependent phosphorylation and relocalization of ERM proteins into apical membrane/actin protrusions in fibroblasts. Mol Biol Cell 1998; 9: 403-19.
26. Matsui T, Maeda M, Doi Y, et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 1998; 140: 647-5.
27. Oelze M, Mollnau H, Hoffmann N, et al. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ Res 2000; 87: 999-1005.
28. Ibarra-Alvarado C, Galle J, Melichar VO, Mameghani A, Schmidt HHHW. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cGMP signaling. Mol Pharmacol 2002; 61: 312-9.
29. Mülsch A, Oelze M, Klöss S, et al. Effects of in vivo nitroglycerin treatment on activity and expression of guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation 2001; 103: 2188-94.
30. Schulz E, Tsilimingas N, Rinze R, et al. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation 2002; 105: 1170-5.
31. Schäfer A, Burkhardt M, Vollkommer T, et al. Endothelium-dependent and -independent relaxation and VASP serines 157/239 phosphorylation by cyclic nucleotide-elevating vasodilators in rat aorta. Biochem Pharmacol 2003; 65: 397-405.
32. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41: 422-33.
33. Wylam ME, Metkus AP, Umans JG. Nitric oxide dependent and independent effects of in vitro incubation or endotoxin on vascular reactivity in rat aorta. Life Sci 2001; 69: 455-67.
34. Farmer MR, Roberts RE, Gardiner SM, Ralevic V. Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney, and aorta. J Pharmacol Exp Ther 2003; 306: 538-45.
35. Heller J, Schepke M, Gehnen N, et al. Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis. Gastroenterology 1999; 116: 387-93.
36. Schepke M, Heller J, Paschke S, et al. Contractile hyporesponsiveness of hepatic arteries in humans with cirrhosis: Evidence for a receptor-specific mechanism. Hepatology 2001; 34: 884-8.
37. Guarner C, Runyon BA, Heck M, Young S, Sheikh MY. Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats. Dig Dis Sci 1999; 44: 1957-62.
38. Plummer JL, Ossowicz CJ, Whibley C, Ilsley AH, Hall PD. Influence of intestinal flora on the development of fibrosis and cirrhosis in a rat model. J Gastroenterol Hepatol 2000; 15: 1307-11.
39. Giacometti A, Cirioni O, Ghiselli R, et al. Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats. Crit Care Med 2006; 34: 2415-20.
40. Rasaratnam B, Kaye D, Jennings G, Dudley F, Chin-Dusting J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med 2003; 139: 186-93.
41. Chin-Dusting JP, Rasaratnam B, Jennings GL, Dudley FJ. Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis. Ann Intern Med 1997; 127: 985-8.
42. Kemp W, Colman J, Thompson K, et al. Norfloxacin treatment for clinically significant portal hypertension: Results of a randomised double-blind placebo-controlled crossover trial. Liver Int 2009; 29: 427-33.
43. Zhou Q, Hennenberg M, Trebicka J, et al. Intrahepatic upregulation of RhoA and Rho-kinase signaling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 2006; 55: 1296-305.
44. Anegawa G, Kawanaka H, Yoshida D, et al. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis. Hepatology 2008; 47: 966-77.
45. Trebicka J, Leifeld L, Hennenberg M, et al. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats. Hepatology 2008; 47: 1264-7.